4-(1-(((9H-Fluoren-9-yl)methoxy)carbonyl)piperidin-4-yl)benzoic acid

Catalog No. :
ACZVFC231
CAS No. :
2137709-91-0
Molecular Formula :
C27H25NO4
Molecular Weight :
427.5

IUPAC Name:4-(1-(((9H-fluoren-9-yl)methoxy)carbonyl)piperidin-4-yl)benzoic acid

4-(1-(((9H-Fluoren-9-yl)methoxy)carbonyl)piperidin-4-yl)benzoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$371.00Login to see priceInquiryInquiry
100mg98%$543.00Login to see priceInquiryInquiry
250mg98%$770.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(1-(((9H-Fluoren-9-yl)methoxy)carbonyl)piperidin-4-yl)benzoic acid
IUPAC Name4-(1-(((9H-fluoren-9-yl)methoxy)carbonyl)piperidin-4-yl)benzoic acid
Molecular FormulaC27H25NO4
Molecular Weight427.5
SMILESO=C(O)C1=CC=C(C2CCN(C(OCC3C4=C(C5=C3C=CC=C5)C=CC=C4)=O)CC2)C=C1
InChI KeyGTEOOIWEXAHOQC-UHFFFAOYSA-N
Synonym4-(1-(((9H-fluoren-9-yl)methoxy)carbonyl)piperidin-4-yl)benzoic acid;1-Piperidinecarboxylic acid, 4-(4-carboxyphenyl)-, 1-(9H-fluoren-9-ylmethyl) ester
CAS No.2137709-91-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACZVFC231 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZVFC231 route product structure diagram
    ACZVFC2312137709-91-0
Inquiry

2. ACZVFC231 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACGMAD024 route compound structure diagram
    ACGMAD024149353-84-4 In Stock
  4. Then
  5. ACZVFC231 route product structure diagram
    ACZVFC2312137709-91-0
Inquiry

Comments (0)